We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.67T
AUM Growth
+$23.3B
Cap. Flow
-$2.36B
Cap. Flow %
-0.14%
Top 10 Hldgs %
22.15%
Holding
8,587
New
427
Increased
3,948
Reduced
2,961
Closed
384

Sector Composition

Rank Sector Weight
1 Technology 22.44%
2 Financials 11.15%
3 Consumer Discretionary 8.06%
4 Healthcare 8.02%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTM
3226
ZoomInfo Technologies
GTM
$967M
$14.5M ﹤0.01%
1,424,261
-1,090,010
-43% -$11.2M
RDW icon
3227
Redwire
RDW
$2.05B
$14.5M ﹤0.01%
1,904,911
-98,642
-5% -$724K
NUEM icon
3228
Nuveen ESG Emerging Markets Equity ETF
NUEM
$362M
$14.5M ﹤0.01%
406,638
+27,490
+7% +$1,000K
UTI icon
3229
Universal Technical Institute
UTI
$2.15B
$14.5M ﹤0.01%
553,417
-140,177
-20% -$3.97M
RYN icon
3230
Rayonier
RYN
$6.64B
$14.5M ﹤0.01%
667,480
+6,039
+0.9% +$137K
DAWN
3231
DELISTED
Day One Biopharmaceuticals
DAWN
$14.4M ﹤0.01%
1,550,274
+246,245
+19% +$2.06M
VSTM icon
3232
Verastem
VSTM
$547M
$14.4M ﹤0.01%
1,871,562
+292,076
+18% +$2.6M
FUMB icon
3233
First Trust Ultra Short Duration Municipal ETF
FUMB
$246M
$14.4M ﹤0.01%
720,112
-176,938
-20% -$3.55M
KURA icon
3234
Kura Oncology
KURA
$826M
$14.4M ﹤0.01%
1,389,828
-423,236
-23% -$4.44M
GMF icon
3235
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$417M
$14.4M ﹤0.01%
104,033
+53,019
+104% +$7.41M
FLGB icon
3236
Franklin FTSE United Kingdom ETF
FLGB
$900M
$14.4M ﹤0.01%
427,640
-6,246
-1% -$205K
CZA icon
3237
Invesco Zacks Mid-Cap ETF
CZA
$192M
$14.4M ﹤0.01%
130,230
+1,176
+0.9% +$130K
CENTA icon
3238
Central Garden & Pet Co Class A
CENTA
$2.44B
$14.4M ﹤0.01%
494,052
+23,760
+5% +$687K
SEM
3239
DELISTED
Select Medical
SEM
$14.4M ﹤0.01%
966,710
-252,043
-21% -$3.56M
FLNG icon
3240
FLEX LNG
FLNG
$1.67B
$14.3M ﹤0.01%
575,120
+36,379
+7% +$928K
COUR icon
3241
Coursera
COUR
$1.68B
$14.3M ﹤0.01%
1,948,478
-480,348
-20% -$4.18M
ANNX icon
3242
Annexon
ANNX
$814M
$14.3M ﹤0.01%
2,856,143
-173,705
-6% -$664K
CHA
3243
Chagee Holdings Ltd
CHA
$2.22B
$14.3M ﹤0.01%
1,231,261
+298,770
+32% +$4.44M
EBS icon
3244
Emergent Biosolutions
EBS
$377M
$14.3M ﹤0.01%
1,157,696
+628,821
+119% +$6.74M
THW
3245
abrdn World Healthcare Fund
THW
$539M
$14.3M ﹤0.01%
1,116,058
+101,339
+10% +$1.29M
HTH icon
3246
Hilltop Holdings
HTH
$2.28B
$14.3M ﹤0.01%
420,004
-27,941
-6% -$937K
FINV
3247
FinVolution Group
FINV
$1.16B
$14.2M ﹤0.01%
2,722,051
+66,714
+3% +$392K
ATEN icon
3248
A10 Networks
ATEN
$2.25B
$14.2M ﹤0.01%
804,350
+48,874
+6% +$866K
BME icon
3249
BlackRock Health Sciences Trust
BME
$567M
$14.2M ﹤0.01%
345,789
+16,856
+5% +$666K
ECC
3250
Eagle Point Credit Company
ECC
$497M
$14.2M ﹤0.01%
2,467,854
+755,471
+44% +$4.59M

Similar funds

Morgan Stanley's Q4 2025 Portfolio in Review

As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
  • Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
  • Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
  • Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
  • Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
  • Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
  • Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.